Further, knockout of the Col4a3 gene led to the marked upregulation of fibrosis markers such as α-SMA and fibronectin, which was suppressed by Ang-[1–7] treatment, indicating protection against renal fibrosis at the gene transcription level. The gene discussed is ACTA1; the disease is renal fibrosis.